Placebo to risedronate

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Paget's Disease of Bone

Phase 3

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

CompletedNCT00051636

Novartis PharmaceuticalsPaget's Disease of Bone

Start: 2001-01-31End: 2011-04-30Updated: 2012-05-15

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

CompletedNCT00103740

Novartis PharmaceuticalsPaget's Disease of Bone

Start: 2002-04-30End: 2011-04-30Updated: 2012-06-04